JP2005002041A - Water-soluble pearl powder - Google Patents

Water-soluble pearl powder Download PDF

Info

Publication number
JP2005002041A
JP2005002041A JP2003166904A JP2003166904A JP2005002041A JP 2005002041 A JP2005002041 A JP 2005002041A JP 2003166904 A JP2003166904 A JP 2003166904A JP 2003166904 A JP2003166904 A JP 2003166904A JP 2005002041 A JP2005002041 A JP 2005002041A
Authority
JP
Japan
Prior art keywords
pearl powder
water
soluble
calcium lactate
soluble pearl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003166904A
Other languages
Japanese (ja)
Inventor
Tatsuo Inagawa
竜男 稲川
Shisen Chin
志泉 沈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEDI CUBE CO Ltd
Original Assignee
MEDI CUBE CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MEDI CUBE CO Ltd filed Critical MEDI CUBE CO Ltd
Priority to JP2003166904A priority Critical patent/JP2005002041A/en
Publication of JP2005002041A publication Critical patent/JP2005002041A/en
Pending legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide water-soluble pearl powder high in absorbability into human body and rich in nutrients, and to provide a method for producing the water-soluble pearl powder. <P>SOLUTION: This water-soluble pearl powder contains calcium lactate. The method for producing the water-soluble pearl powder comprises the steps of washing, drying and grinding pearls to obtain pearl powder, adding lactic acid to the pearl powder to obtain a calcium lactate solution, adding a protease to the above-obtained pearl powder to obtain a proteolysis product, and adding the proteolysis product to the calcium lactate. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

【0001】
【発明の属する技術分野】
本発明は、乳酸カルシウムを含むことを特徴とする、水溶性真珠粉及びその製造方法に関する。
【0002】
また、本発明は、下記工程:
真珠を洗浄し、乾燥させ、粉砕し真珠粉を得る工程、
得られた真珠粉に乳酸を加え、乳酸カルシウム溶液を得る工程、
得られた真珠粉にタンパク質分解酵素を加え、タンパク質分解物を得る工程
得られたタンパク質分解物を乳酸カルシウムに加える工程
を含むことを特徴とする、
乳酸カルシウムを含む水溶性真珠粉の製造方法に関する。
【0003】
【従来の技術】
真珠は、中国伝統の薬剤として、代代の皇帝や貴族の間で珍重されてきたことが知られている。明の時代の薬物書である「本草綱目」にも、真珠粉のことが詳しく紹介されており、精神安定、目のかすみをとる、顔に塗れば血色をよくする、手足に塗れば皮膚荒れ湿疹をとる等の効果が記載されている。
現代科学の解明により、真珠粉は、皮膚のコラーゲンの増加、メラニン色素の増加抑制、細胞の老化防止及び乾燥によるシワの防止の効果を有することが解明されてきた。
しかし、一般的な真珠粉は、真珠をそのまま粉砕したものであり、人体への吸収率も10〜20%程度とされており、人体への吸収がより高い真珠粉の開発が待たれていた。
【0004】
本発明者は、鋭意研究を行った結果、乳酸を加えることによってカルシウムを分離し、酵素でおだやかに真珠タンパク質を分解し、得られたタンパク質分解物を乳酸カルシウムに加えることによって、人体への吸収率が高く、栄養成分が豊富な水溶性真珠粉を得ることができることを発見し、本発明を完成させた。
【0005】
【発明が解決しようとする課題】
本発明は、乳酸カルシウムを含むことを特徴とする、水溶性真珠粉及びその製造方法を提供することを目的とする。
【0006】
【課題を解決するための手段】
本発明は、乳酸カルシウムを含むことを特徴とする、水溶性真珠粉に関する。
本発明の水溶性真珠粉の製造方法は、下記工程:
真珠を洗浄し、乾燥させ、粉砕し真珠粉を得る工程、
得られた真珠粉に乳酸を加え、乳酸カルシウム溶液を得る工程、
得られた真珠粉にタンパク質分解酵素を加え、タンパク質分解物を得る工程
得られたタンパク質分解物を乳酸カルシウムに加える工程
を含む。
【0007】
下記において、本発明の製造方法をより具体的に説明する。
真珠は、淡水真珠及び海水真珠を用いることができる。海水真珠は核として貝殻を用いるが、淡水真珠は、貝殻ではなく貝肉を用いている。核として用いられた貝肉は真珠層に吸収され、そのまま粉砕しても貝殻分が混入しないことから、好ましくは、淡水真珠が用いられる。選別は、目視で行い、形の良い真珠は、宝飾品として用いられ、それ以外の真珠を本発明に用いることができる。
【0008】
真珠を蒸留水で洗浄し、塵や泥を取り除く。次に、洗浄された真珠を乾燥機に入れ、乾燥する。乾燥温度は、50〜150℃、好ましくは、80〜120℃、より好ましくは、100℃で行うことができる。乾燥時間は、真珠の量によって異なるが、例えば、100℃、8時間で約50kgの真珠を乾燥することができる。
乾燥した真珠を、粉砕機に入れ、細かく粉砕する。粉砕は、常温で行うことができる。1時間当たりの真珠粉砕量は、約5kgであり、粉砕された真珠の直径は、約150μmである。
粉砕された真珠に乳酸を加え(例えば、乳酸濃度20%、温度60℃で1時間に約5kgを生産することができる)、不溶性真珠カルシウム(炭酸カルシウム)を水溶性乳酸カルシウムに変化させ、乳酸カルシウム水溶液を得る。これによって、カルシウムの人体への吸収率を高くすることができる。
得られたタンパク質をタンパク質分解酵素によってアミノ酸レベルまで分解する。
得られたアミノ酸を乳酸カルシウム水溶液に加え、結晶させ、乾燥し、これを粉砕し、本発明の真珠粉を得る。
【0009】
本発明の水溶性真珠粉は、(1)美容効果、(2)女性生理機能改善効果及び(3)睡眠改善効果を有する。
【0010】
(1)美容効果としては、皮膚の角質層への保水効果、血液浄化作用と血液粘度低下、血中脂肪を低減し、血液循環を改善することによる皮膚の老化防止効果、及び消化機能を調節し、老廃物を排出することによるニキビ、湿疹等の予防効果が挙げられる。
【0011】
(2)女性生理機能改善効果としては、体内の生理機能調節作用により初潮期の少女と女性生理時障害の改善、すなわち、下記の症状に対する補助治療効果が認められる。
・生理不順
・出血量のばらつき
・生理期間が長い
・腰痛
・めまい
・集中力低下
・更年期障害
【0012】
(3)睡眠改善効果としては、精神を安定させ、ストレスを改善し、眠りを深くする等の効果を有する。
本発明の水溶性真珠粉は、朝晩各一回、0.3〜0.5gを水又はお湯に溶かして飲むことができる。また、蜂蜜や牛乳等に混ぜて飲むこともできる。
また、本発明の水溶性真珠粉は、外用として、洗面後に、水溶液を顔につけて軽くマッサージすることもできる。この場合、蒸気又は蒸しタオルを併用するとより効果的である。卵白や牛乳に混ぜて、朝晩のパックに利用することもできる。湿疹、あせも、アトピーには、水溶液を直接適用するか、又はフェイスクリームなどに混ぜて適用することができる。
【0013】
【実施例】
以下、本発明を実施例により詳細に説明をするが、これらに制限されるものではない。
1.真珠粉の製造
上記の製造方法にしたがって、養殖した淡水真珠を用いて水溶性真珠粉を製造した。養殖池の水は、中国太湖より引かれていた。真珠を目視で選別し、形の良いものを宝飾品とし、それ以外のものを本発明の水溶性真珠粉の製造に用いた。
【0014】
2.真珠粉の分析値
本発明の水溶性真珠粉末の組成を分析したところ下記の値を得た。
項目 検出値
タンパク質 1.8%
pH 4.5〜6.5
鉄 21.7mg/kg
亜鉛 4.6mg/kg
カルシウム 16.6g/100g
マグネシウム 0.5g/100g
セレニウム <0.3μg/100g
マンガン 208.7mg/kg
ナマリ 0.5mg/kg
砒素 <0.2mg・kg
一般生菌数 <10cfu/g
大腸菌群 <3MPN/100g
病原菌 検出せず
また、本発明の水溶性真珠粉末のアミノ酸組成を分析したところ下記の値を得た。
項目 検出値(%)
水溶性アミノ酸合計 1.19
アスパラギン酸 検出せず
スレオニン 0.06
セリン 0.04
グルタミン酸 0.24
グリシン 0.29
アラニン 0.13
バリン 0.04
メチオニン 0.01
イソロイシン 0.01
リシン 0.03
チロシン 0.01
フェニルアラアラニン 0.02
ヒスチジン 0.01
ロイシン 0.04
NH 0.01
アルギニン 0.08
シスチン 0.02
プロリン 0.15
【0015】
3.毒性試験結果
実験用ラット(体重18〜22g、雌雄各5匹/群)に水溶性真珠粉を経口で1回投与し、2週間の急性毒性レベルを測定した。
本発明の水溶性真珠粉(乳白色)を蒸留水に溶解し、1000,2150,4640,10000mg/kgの用量でラットに投与した。投与量は,0.1ml/10g体重とした。投与後、ラットの一般状態、中毒状態、死亡状態を2週間観察した。Horn’s法に基づき、LD50値を求めた。
その結果、いずれの群においても、死亡例は、認められなかった。また、一般状態への影響や中毒症状も認められなかった。
したがって、本発明の水溶性真珠粉のラットに対する最大10000mg/kg体重のLD50値は、急性毒性レベル基準によると「無毒」に属する。
[0001]
BACKGROUND OF THE INVENTION
The present invention relates to a water-soluble pearl powder containing calcium lactate and a method for producing the same.
[0002]
The present invention also includes the following steps:
Washing pearls, drying, crushing to obtain pearl powder,
Adding lactic acid to the obtained pearl powder to obtain a calcium lactate solution,
A step of adding a proteolytic enzyme to the obtained pearl powder to obtain a proteolytic product includes a step of adding the proteolytic product obtained to calcium lactate,
The present invention relates to a method for producing a water-soluble pearl powder containing calcium lactate.
[0003]
[Prior art]
It is known that pearls have been prized as a traditional Chinese medicine among the generations of emperors and aristocrats. The “Hakuso Tuname”, a drug book of the Ming Dynasty, also introduces pearl powder in detail. It stabilizes the skin, removes blurring of the eyes, improves the color when applied to the face, and rough skin when applied to the limbs. Effects such as taking eczema are described.
Through the elucidation of modern science, it has been elucidated that pearl powder has an effect of increasing skin collagen, suppressing increase of melanin pigment, preventing aging of cells and preventing wrinkles by drying.
However, general pearl powder is obtained by pulverizing pearls as they are, and the absorption rate to the human body is about 10 to 20%, and the development of pearl powder with higher absorption to the human body has been awaited. .
[0004]
As a result of diligent research, the present inventor has separated calcium by adding lactic acid, gently decomposes pearl protein with an enzyme, and adds the obtained proteolysate to calcium lactate to absorb it into the human body. It was discovered that a water-soluble pearl powder having a high rate and rich in nutritional components can be obtained, and the present invention has been completed.
[0005]
[Problems to be solved by the invention]
It is an object of the present invention to provide a water-soluble pearl powder containing calcium lactate and a method for producing the same.
[0006]
[Means for Solving the Problems]
The present invention relates to a water-soluble pearl powder containing calcium lactate.
The method for producing the water-soluble pearl powder of the present invention includes the following steps:
Washing pearls, drying, crushing to obtain pearl powder,
Adding lactic acid to the obtained pearl powder to obtain a calcium lactate solution,
A step of adding a proteolytic enzyme to the obtained pearl powder to obtain a protein degradation product includes a step of adding the obtained protein degradation product to calcium lactate.
[0007]
Below, the manufacturing method of this invention is demonstrated more concretely.
As the pearl, a freshwater pearl and a seawater pearl can be used. Seawater pearls use shells as the core, but freshwater pearls use shellfish instead of shells. Since the shellfish used as the core is absorbed by the pearl layer and the shell is not mixed even if crushed as it is, freshwater pearls are preferably used. Sorting is performed visually, and pearls with good shape are used as jewelry, and other pearls can be used in the present invention.
[0008]
Wash pearls with distilled water to remove dust and mud. Next, the washed pearl is put into a dryer and dried. The drying temperature can be 50 to 150 ° C, preferably 80 to 120 ° C, more preferably 100 ° C. The drying time varies depending on the amount of pearls. For example, about 50 kg of pearls can be dried at 100 ° C. for 8 hours.
The dried pearl is put into a pulverizer and pulverized finely. The pulverization can be performed at room temperature. The amount of pearls crushed per hour is about 5 kg, and the diameter of the crushed pearls is about 150 μm.
Lactic acid is added to the crushed pearl (for example, about 5 kg can be produced at an lactic acid concentration of 20% and a temperature of 60 ° C. per hour), and insoluble pearl calcium (calcium carbonate) is changed to water-soluble calcium lactate, An aqueous calcium solution is obtained. Thereby, the absorption rate of calcium into the human body can be increased.
The resulting protein is degraded to the amino acid level by proteolytic enzymes.
The obtained amino acid is added to an aqueous calcium lactate solution, crystallized, dried, and pulverized to obtain the pearl powder of the present invention.
[0009]
The water-soluble pearl powder of the present invention has (1) a cosmetic effect, (2) a female physiological function improving effect, and (3) a sleep improving effect.
[0010]
(1) Cosmetic effects include water retention effect on the skin's stratum corneum, blood purification and blood viscosity reduction, blood fat reduction, blood circulation improvement and skin digestion prevention effect, and regulation of digestive function In addition, the prevention of acne, eczema and the like by discharging waste products.
[0011]
(2) As a female physiological function improvement effect, improvement of menstrual disorders and female physiological disorders by the physiological function regulating action in the body, that is, an auxiliary treatment effect for the following symptoms is recognized.
・ Failure of menstruation ・ Dispersion of bleeding amount ・ Long periods of menstruation ・ Low back pain ・ Dizziness ・ Low concentration ・ Menopause [0012]
(3) The sleep improvement effect has effects such as stabilizing the mind, improving stress, and deepening sleep.
The water-soluble pearl powder of the present invention can be taken by dissolving 0.3 to 0.5 g in water or hot water once each morning and night. It can also be mixed with honey or milk.
Moreover, the water-soluble pearl powder of the present invention can be lightly massaged by applying an aqueous solution to the face after washing the face for external use. In this case, it is more effective to use steam or steam towel together. It can be mixed with egg white or milk and used for morning and evening packs. For eczema, ash, and atopy, an aqueous solution can be applied directly or mixed with face cream or the like.
[0013]
【Example】
EXAMPLES Hereinafter, although an Example demonstrates this invention in detail, it is not restrict | limited to these.
1. Manufacture of pearl powder According to said manufacturing method, the water-soluble pearl powder was manufactured using the cultured freshwater pearl. The water in the aquaculture pond was drawn from Taihu Lake, China. The pearls were visually selected, and those having good shapes were used as jewelry, and the others were used for producing the water-soluble pearl powder of the present invention.
[0014]
2. Analysis value of pearl powder The composition of the water-soluble pearl powder of the present invention was analyzed and the following values were obtained.
Item Detection value Protein 1.8%
pH 4.5-6.5
Iron 21.7mg / kg
Zinc 4.6mg / kg
Calcium 16.6g / 100g
Magnesium 0.5g / 100g
Selenium <0.3μg / 100g
Manganese 208.7mg / kg
Namari 0.5mg / kg
Arsenic <0.2mg ・ kg
General viable count <10 cfu / g
Coliforms <3MPN / 100g
The pathogen was not detected, and the amino acid composition of the water-soluble pearl powder of the present invention was analyzed, and the following values were obtained.
Item Detection value (%)
Water-soluble amino acids total 1.19
Aspartic acid not detected Threonine 0.06
Serine 0.04
Glutamic acid 0.24
Glycine 0.29
Alanine 0.13
Valine 0.04
Methionine 0.01
Isoleucine 0.01
Lysine 0.03
Tyrosine 0.01
Phenylaraalanine 0.02
Histidine 0.01
Leucine 0.04
NH 3 0.01
Arginine 0.08
Cystine 0.02
Proline 0.15
[0015]
3. Toxicity test results The water-soluble pearl powder was orally administered once to experimental rats (body weight 18 to 22 g, 5 males and 5 females / group), and the acute toxicity level for 2 weeks was measured.
The water-soluble pearl powder (milky white) of the present invention was dissolved in distilled water and administered to rats at doses of 1000, 2150, 4640, and 10000 mg / kg. The dose was 0.1 ml / 10 g body weight. After administration, the rats were observed for general condition, poisoning, and death for 2 weeks. Based on Horn's method, LD 50 value was obtained.
As a result, there were no deaths in any group. In addition, there were no effects on general condition or toxic symptoms.
Therefore, the LD 50 value of up to 10,000 mg / kg body weight for rats of the water-soluble pearl powder of the present invention belongs to “non-toxic” according to the acute toxicity level criteria.

Claims (2)

乳酸カルシウムを含むことを特徴とする、水溶性真珠粉。Water-soluble pearl powder characterized by containing calcium lactate. 下記工程:
真珠を洗浄し、乾燥させ、粉砕し真珠粉を得る工程、
得られた真珠粉に乳酸を加え、乳酸カルシウム溶液を得る工程、
得られた真珠粉にタンパク質分解酵素を加え、タンパク質分解物を得る工程
得られたタンパク質分解物を乳酸カルシウムに加える工程
を含むことを特徴とする、
乳酸カルシウムを含む水溶性真珠粉の製造方法。
The following process:
Washing pearls, drying, crushing to obtain pearl powder,
Adding lactic acid to the obtained pearl powder to obtain a calcium lactate solution,
A step of adding a proteolytic enzyme to the obtained pearl powder to obtain a proteolytic product includes a step of adding the proteolytic product obtained to calcium lactate,
A method for producing water-soluble pearl powder containing calcium lactate.
JP2003166904A 2003-06-11 2003-06-11 Water-soluble pearl powder Pending JP2005002041A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003166904A JP2005002041A (en) 2003-06-11 2003-06-11 Water-soluble pearl powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003166904A JP2005002041A (en) 2003-06-11 2003-06-11 Water-soluble pearl powder

Publications (1)

Publication Number Publication Date
JP2005002041A true JP2005002041A (en) 2005-01-06

Family

ID=34092913

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003166904A Pending JP2005002041A (en) 2003-06-11 2003-06-11 Water-soluble pearl powder

Country Status (1)

Country Link
JP (1) JP2005002041A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014051440A (en) * 2012-09-05 2014-03-20 Mikimoto Pharmaceut Co Ltd Metallothionein production accelerator and antioxidant
JP5760280B1 (en) * 2014-05-12 2015-08-05 株式会社東洋新薬 Effervescent skin external preparation
JP2017513923A (en) * 2014-03-14 2017-06-01 欧詩漫生物股▲ふん▼有限公司Osmun Biological Co., Ltd Method for separating and producing pearl extract from a kind of pearl
CN107495336A (en) * 2017-08-01 2017-12-22 苏州太湖美药业有限公司 A kind of preparation method of soluble pearl powder
JP2018507904A (en) * 2015-03-17 2018-03-22 欧詩漫生物股▲ふん▼有限公司Osm Biology Co., Ltd. A kind of cosmetic composition used for skin whitening and its preparation method
CN113049729A (en) * 2021-03-10 2021-06-29 广西中医药大学 Control method for pearl quality standard in pearl compound preparation
CN113663566A (en) * 2021-08-23 2021-11-19 亳州市永刚饮片厂有限公司 Pearl powder production process
CN115282168A (en) * 2022-08-30 2022-11-04 马应龙大健康有限公司 Soothing moisturizer for relieving infantile eczema symptom and preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041613A (en) * 1983-08-12 1985-03-05 Shigeo Yamamoto Pearl extract having high absorbability and its production
JP2002068993A (en) * 2000-08-30 2002-03-08 Maruzen Pharmaceut Co Ltd Epidermal keratinizing cell propagation-accelerating agent, beautifying food and skin cosmetic
JP2002226323A (en) * 2001-02-02 2002-08-14 Maruzen Pharmaceut Co Ltd Collagen production promoter, collagenase inhibitor, fibroblast proliferation agent, elastase inhibitor, estrogen-like action agent, skin cosmetic, and beautifying drink or food
JP2002302452A (en) * 2001-04-02 2002-10-18 Maruzen Pharmaceut Co Ltd Histamine separation inhibitor, cyclic amp phosphodiesterase inhibitor, active oxygen scavenger and radical scavenger

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041613A (en) * 1983-08-12 1985-03-05 Shigeo Yamamoto Pearl extract having high absorbability and its production
JP2002068993A (en) * 2000-08-30 2002-03-08 Maruzen Pharmaceut Co Ltd Epidermal keratinizing cell propagation-accelerating agent, beautifying food and skin cosmetic
JP2002226323A (en) * 2001-02-02 2002-08-14 Maruzen Pharmaceut Co Ltd Collagen production promoter, collagenase inhibitor, fibroblast proliferation agent, elastase inhibitor, estrogen-like action agent, skin cosmetic, and beautifying drink or food
JP2002302452A (en) * 2001-04-02 2002-10-18 Maruzen Pharmaceut Co Ltd Histamine separation inhibitor, cyclic amp phosphodiesterase inhibitor, active oxygen scavenger and radical scavenger

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014051440A (en) * 2012-09-05 2014-03-20 Mikimoto Pharmaceut Co Ltd Metallothionein production accelerator and antioxidant
JP2017513923A (en) * 2014-03-14 2017-06-01 欧詩漫生物股▲ふん▼有限公司Osmun Biological Co., Ltd Method for separating and producing pearl extract from a kind of pearl
JP5760280B1 (en) * 2014-05-12 2015-08-05 株式会社東洋新薬 Effervescent skin external preparation
JP2018507904A (en) * 2015-03-17 2018-03-22 欧詩漫生物股▲ふん▼有限公司Osm Biology Co., Ltd. A kind of cosmetic composition used for skin whitening and its preparation method
CN107495336A (en) * 2017-08-01 2017-12-22 苏州太湖美药业有限公司 A kind of preparation method of soluble pearl powder
CN113049729A (en) * 2021-03-10 2021-06-29 广西中医药大学 Control method for pearl quality standard in pearl compound preparation
CN113049729B (en) * 2021-03-10 2023-04-25 广西中医药大学 Control method of pearl quality standard in pearl compound preparation
CN113663566A (en) * 2021-08-23 2021-11-19 亳州市永刚饮片厂有限公司 Pearl powder production process
CN113663566B (en) * 2021-08-23 2023-10-31 亳州市永刚饮片厂有限公司 Pearl powder production process
CN115282168A (en) * 2022-08-30 2022-11-04 马应龙大健康有限公司 Soothing moisturizer for relieving infantile eczema symptom and preparation method and application thereof
CN115282168B (en) * 2022-08-30 2024-05-31 马应龙大健康有限公司 Soothing skin cream for relieving infant eczema symptoms and preparation method and application thereof

Similar Documents

Publication Publication Date Title
Sneddon Adverse effect of topical fluorinated corticosteroids in rosacea
TWI516280B (en) Use of chenopodium formosanum extract for manufacture of composition for enhancing secretion of collagen and preventing cutaneous aging
US9060958B2 (en) Tyrosinase inhibitor produced using dried earthworm powder, and method for producing same
JPH11106336A (en) Maillard reaction inhibitor
JPH1053532A (en) Antiallergic drug containing plant extract
WO2017148180A1 (en) Rosemary moisturizing solution and manufacturing method therefor
JPH0987189A (en) Antiallergic agent containing isodon japonicus hara, paeonia suffruticosa andrews, perilla frutescens britton var. acuta kudo, and/or arunica montana linne
JP4505707B2 (en) Pharmaceutical composition for the treatment of stiff shoulders or coldness due to vasodilation
JP4755325B2 (en) Bioactive composition derived from silk protein hydrolyzate
JP4917584B2 (en) Processed solubilized bees, method for producing the same, antioxidant, ACE inhibitor, antihypertensive agent, dermal fibroblast proliferation promoter, fatigue recovery agent, blood flow improving agent, and solubilized bees Pharmaceuticals, cosmetics or food / drinks contained
JP2007211183A (en) Puffer fish-originated collagen, derivative thereof and method for producing the same, and cosmetic containing the collagen and derivative thereof
JP2005002041A (en) Water-soluble pearl powder
JP2007022958A (en) Atelocollagen and/or its derivative derived from squid or catfish, method for producing the same, and cosmetic compounded of the atelocollagen and/or its derivative
JPH11332527A (en) Production of extract of edible swallow&#39;s nest and health food, cosmetic or the like containing edible bird&#39;s nest
AU2018203661A1 (en) Composition for reducing skin wrinkles and improving skin elasticity comprising radish extract
CN110157758A (en) The purposes of the Flos Rosae Rugosas pollen polypeptide of fermentation method preparation
JP2002125662A (en) Non-deactivated enzyme-reinforced composition
JP2000143524A (en) Antiinflammatory agent containing extract of amaranthus
JP2002316937A (en) Plant extract-containing anti-allergic agent
JP2001501976A (en) Method for stabilizing levogyre ascorbic acid (LAA) and stable LAA composition
JP2004229534A (en) Hydrolyzed eggshell membrane-containing drink
US10155012B2 (en) Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency
JPH09507237A (en) Composition of turtle and turtle
JP2000281528A (en) Cosmetic composition
JP2011116761A (en) Antioxidative peptide derived from royal jelly

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060511

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091104

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100427